- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Src in endometriosis-associated ovarian cancer
Authors
Keywords
-
Journal
Oncogenesis
Volume 5, Issue 8, Pages e251-e251
Publisher
Springer Nature
Online
2016-08-15
DOI
10.1038/oncsis.2016.54
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis
- (2015) Kate Lawrenson et al. INTERNATIONAL JOURNAL OF CANCER
- Castration-Resistant Prostate Cancer Bone Metastasis Response Measured by 18F-Fluoride PET After Treatment with Dasatinib and Correlation with Progression-Free Survival: Results from American College of Radiology Imaging Network 6687
- (2015) E. Y. Yu et al. JOURNAL OF NUCLEAR MEDICINE
- A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer†
- (2014) I. A. McNeish et al. ANNALS OF ONCOLOGY
- Dasatinib (BMS-35482) Interacts Synergistically With Docetaxel, Gemcitabine, Topotecan, and Doxorubicin in Ovarian Cancer Cells With High SRC Pathway Activation and Protein Expression
- (2014) Angeles Alvarez Secord et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Novel three-dimensional in vitro models of ovarian endometriosis
- (2014) Doerthe Brueggmann et al. Journal of Ovarian Research
- Targeting Src and Tubulin in Mucinous Ovarian Carcinoma
- (2013) T. Liu et al. CLINICAL CANCER RESEARCH
- Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
- (2013) John H. Strickler et al. INVESTIGATIONAL NEW DRUGS
- A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro
- (2013) Janet Myungjin Lee et al. LABORATORY INVESTIGATION
- A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer
- (2012) A. A. Secord et al. CLINICAL CANCER RESEARCH
- Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma
- (2012) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2012) Russell J. Schilder et al. GYNECOLOGIC ONCOLOGY
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
- (2012) Celeste Leigh Pearce et al. LANCET ONCOLOGY
- BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence
- (2012) Weiya Z. Wysham et al. PLoS One
- Targeting Src in Mucinous Ovarian Carcinoma
- (2011) Koji Matsuo et al. CLINICAL CANCER RESEARCH
- Functional Roles of Src and Fgr in Ovarian Carcinoma
- (2011) H.-S. Kim et al. CLINICAL CANCER RESEARCH
- Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers
- (2011) William J. Lowery et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- 14-3-3σ Expression and prognostic value in patients with epithelial ovarian carcinoma: A high throughput tissue microarray analysis
- (2008) P. Mhawech-Fauceglia et al. EJSO
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now